AstraZeneca PLC ADR Rises Tuesday, Outperforms Market

Dow Jones11-26

DJ AstraZeneca PLC ADR Rises Tuesday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

The AstraZeneca PLC ADR $(AZN)$ rose 1.88% to $93.24 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.67% to 23,025.59 and the Dow Jones Industrial Average rising 1.43% to 47,112.45.

This was the ADR's third consecutive day of gains.

AstraZeneca PLC ADR hit a new 52-week high, surpassing its previous peak of $91.91, which the company achieved on November 21st.

The ADR demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly & Co. $(LLY)$ rose 3.72% to $1,109.94, Biogen Inc. $(BIIB)$ rose 2.91% to $181.96, and Johnson & Johnson $(JNJ)$ rose 0.94% to $206.67.

Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

November 25, 2025 17:21 ET (22:21 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2586404453?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-26 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2586404453","market":"fut","top_or_hot":-1,"title":"AstraZeneca PLC ADR Rises Tuesday, Outperforms Market","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ AstraZeneca PLC ADR Rises Tuesday, Outperforms Market\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     The AstraZeneca PLC ADR <a href=\"https://laohu8.com/S/AZN\">$(AZN)$</a> rose 1.88% to $93.24 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.67% to 23,025.59 and the Dow Jones Industrial Average  rising 1.43% to 47,112.45. \n</p>\n<p>\n     This was the ADR's third consecutive day of gains. \n</p>\n<p>\n     AstraZeneca PLC ADR hit a new 52-week high, surpassing its previous peak of $91.91, which the company achieved on November 21st. \n</p>\n<p>\n     The ADR demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly &amp; Co. <a href=\"https://laohu8.com/S/LLY\">$(LLY)$</a> rose 3.72% to $1,109.94, Biogen Inc. <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> rose 2.91% to $181.96, and Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.94% to $206.67. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 25, 2025 17:21 ET (22:21 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca PLC ADR Rises Tuesday, Outperforms Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca PLC ADR Rises Tuesday, Outperforms Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-26 06:21</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ AstraZeneca PLC ADR Rises Tuesday, Outperforms Market\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     The AstraZeneca PLC ADR <a href=\"https://laohu8.com/S/AZN\">$(AZN)$</a> rose 1.88% to $93.24 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.67% to 23,025.59 and the Dow Jones Industrial Average  rising 1.43% to 47,112.45. \n</p>\n<p>\n     This was the ADR's third consecutive day of gains. \n</p>\n<p>\n     AstraZeneca PLC ADR hit a new 52-week high, surpassing its previous peak of $91.91, which the company achieved on November 21st. \n</p>\n<p>\n     The ADR demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly &amp; Co. <a href=\"https://laohu8.com/S/LLY\">$(LLY)$</a> rose 3.72% to $1,109.94, Biogen Inc. <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> rose 2.91% to $181.96, and Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.94% to $206.67. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 25, 2025 17:21 ET (22:21 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AZN","symbol_name":"阿斯利康","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2586404453","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2586404453","pubTimestamp":1764109260,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The AstraZeneca PLC ADR  rose 1.88% to $93.24 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.67% to 23,025.59 and the Dow Jones Industrial Average  rising 1.43% to 47,112.45.This was the ADR's third consecutive day of gains.AstraZeneca PLC ADR hit a new 52-week high, surpassing its previous peak of $91.91, which the company achieved on November 21st.The ADR demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly & Co.  rose 3.72% to $1,109.94, Biogen Inc.  rose 2.91% to $181.96, and Johnson & Johnson  rose 0.94% to $206.67.Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"AZN":"阿斯利康"},"translate_title":"阿斯利康公司ADR周二上涨，跑赢大盘","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":1.5},"content_text":"DJ AstraZeneca PLC ADR Rises Tuesday, Outperforms Market\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     The AstraZeneca PLC ADR $(AZN)$ rose 1.88% to $93.24 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.67% to 23,025.59 and the Dow Jones Industrial Average  rising 1.43% to 47,112.45. \n\n\n     This was the ADR's third consecutive day of gains. \n\n\n     AstraZeneca PLC ADR hit a new 52-week high, surpassing its previous peak of $91.91, which the company achieved on November 21st. \n\n\n     The ADR demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly & Co. $(LLY)$ rose 3.72% to $1,109.94, Biogen Inc. $(BIIB)$ rose 2.91% to $181.96, and Johnson & Johnson $(JNJ)$ rose 0.94% to $206.67. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2025 17:21 ET (22:21 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2586404453","isCrawlerRequest":true}